# US 2003/0211180 A1 · Herbal composition phy906 and its use in chemotheraphy

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0211180 A1
- Document ID: US20030211180A1
- Status: Published application
- Kind: A1
- Application number: 10/220,876
- Filed: 2002-12-30
- Published: 2003-11-13
- Earliest claimed: 2000-03-09
- Assignees: Yale University
- Inventors: Yung-Chi Cheng; Shwu-Huey Liu
- Web page: https://patentgrep.com/patent/US20030211180A1

## CPC

- A61K 36/48: Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K 36/484: Glycyrrhiza (licorice)
- A61K 36/539: Scutellaria (skullcap)
- A61K 36/65: Paeoniaceae (Peony family), e.g. Chinese peony
- A61K 36/725: Ziziphus, e.g. jujube
- A61P 1/16: for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A61P 7/00: Drugs for disorders of the blood or the extracellular fluid
- A61P 31/12: Antivirals
- A61P 31/14: for RNA viruses
- A61P 31/18: for HIV
- A61P 31/20: for DNA viruses
- A61P 31/22: for herpes viruses
- A61P 35/00: Antineoplastic agents
- A61P 37/00: Drugs for immunological or allergic disorders
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

This invention provides herbal compositions useful for increasing the therapeutic index of drugs, including those used in the treatment of disease, especially viral infections and neoplasms of cancer. This invention provides methods useful for improving the quality of life of an individual undergoing chemotherapy. Furthermore, this invention improves the treatment of disease by increasing the therapeutic index of chemotherapy drugs by administering the herbal composition PHY906 to a person undergoing such chemotherapy.

## Claims

### Claim 1

A composition comprising:
i) a pharmaceutically acceptable carrier;
ii) material or chemical from a plant species of each of the following genera of herbs: Scutellaria, Glycyrrhiza, Ziziphus and Paeonia; and
iii) one or more chemotherapeutic compounds.

### Claim 2 (depends on 1)

The composition of claim 1 wherein the plant species are Scutellaria baicalensis, Glycyrrhiza uralensis, Ziziphus jujuba, and Paeonia lactiflora.

### Claim 3 (depends on 1)

The composition of claim 1 wherein the one or more chemotherapeutic compounds are cancer chemotherapeutics.

### Claim 4 (depends on 3)

The composition of claim 3 wherein the cancer chemotherapeutics are selected from the group consisting of an irinotecan formulation, 5-fluorouracil, VP-16 and beta-L-Dioxolane-cytidine.

### Claim 5

A method of increasing the therapeutic index of cancer therapeutic compounds for the treatment of cancer by administering to a mammal in need thereof, a therapeutically effective amount of a composition comprising a pharmaceutically acceptable carrier and a plant species of each of the following genera of herbs: Scutellaria, Glycyrrhiza, Ziziphus and Paeonia.

### Claim 6 (depends on 5)

The method of claim 5, wherein the material from the herbs is in the form of a granulated extract from a concentrated aqueous liquor.

### Claim 7 (depends on 5)

The method of claim 5, wherein the composition is in an ingestible form.

### Claim 8 (depends on 7)

The method of claim 7, wherein the ingestible form is selected from the group consisting of powder, capsule, liquid and tablet.

### Claim 9 (depends on 5)

The method of claim 5 wherein the composition is in the form of a suppository.

### Claim 10 (depends on 5)

The method of claim 5 wherein the mammal is a human.

### Claim 11

A method of treating a disease in a mammal in need thereof which comprises administering a therapeutically effective amount of a composition comprising:
i) a pharmaceutically acceptable carrier;
ii) material or chemical from a plant species of each of the following genera of herbs: Scutellaria, Glycyrrhiza, Ziziphus and Paeonia; and
iii) one or more chemotherapeutic compounds.

### Claim 12 (depends on 11)

The method of claim 11 wherein the mammal is a human.

### Claim 13

A method of treating a disease in a mammal in need thereof which comprises administering a therapeutically effective amount of one or more chemotherapeutic compounds and a composition comprising:
i) a pharmaceutically acceptable carrier;
ii) material or chemical from a plant species of each of the following genera of herbs: Scutellaria, Glycyrrhiza, Ziziphus and Paeonia.

### Claim 14 (depends on 13)

The method of claim 13 wherein the composition is administered before the administration of the one or more chemotherapeutic compounds.

### Claim 15 (depends on 13)

The method of claim 13 wherein the composition is administered after the administration of the one ore more chemotherapeutic compounds.

### Claim 16 (depends on 13)

The method of claim 13 wherein the mammal is a human.

### Claim 17

A method of modulating hematological or immunological activity for the treatment of a disease by administering to a mammal in need thereof, a therapeutically effective amount of a composition consisting essentially of a pharmaceutically acceptable carrier and material from a plant species of each of the following genera of herbs: Scutellaria, Glycyrrhiza, Ziziphus and Paeonia.

### Claim 18 (depends on 17)

The method of claim 17, wherein the material from the herbs is in the form of a granulated extract from a concentrated aqueous liquor.

### Claim 19 (depends on 17)

The method of claim 17 wherein the composition is in an ingestible form.

### Claim 20 (depends on 19)

The method of claim 19 wherein the ingestible form is selected from the group consisting of powder, capsule, liquid and tablet.

### Claim 21 (depends on 17)

The method of claim 17 wherein the composition is in the form of a suppository.

### Claim 22 (depends on 17)

The method of claim 17 wherein the mammal is a human.

### Claim 23

A method of improving the quality of life of a mammal undergoing chemotherapy which comprises administering a therapeutically effective amount of one or more chemotherapeutic compounds and a composition comprising:
i) a pharmaceutically acceptable carrier;
ii) material or chemical from a plant species of each of the following genera of herbs: Scutellaria, Glycyrrhiza, Ziziphus and Paeonia.

### Claim 24 (depends on 23)

The method of claim 23 wherein the mammal is a human.

### Claim 25

A composition comprising:
i) a pharmaceutically acceptable carrier;
ii) an herbal preparation comprising Scutellaria, Glycyrrhiza, Ziziphus and Paeonia; and
iii) a chemotherapeutic formulation comprising a chemotherapeutic compound.

### Claim 26 (depends on 25)

The composition of claim 25 wherein the herbal preparation consists of Scutellaria baicalensis, Glycyrrhiza uralensis, Ziziphus jujuba, and Paeonia lactiflora.

### Claim 27 (depends on 25)

The composition of claim 25, wherein the chemotherapeutic formulation comprises a cancer chemotherapeutic agent.

### Claim 28 (depends on 27)

The composition of claim 27, wherein the cancer chemotherapeutic agent is selected from the group consisting of an irinotecan formulation, 5-fluorouracil, VP-16 and beta-L-Dioxolane-cytidine.

### Claim 29

A method of treating a mammal in need thereof comprising administering a therapeutically effective amount of a composition comprising:
i) a pharmaceutically acceptable carrier;
ii) an herbal preparation comprising Scutellaria, Glycyrrhiza, Ziziphus and Paeonia; and
iii) a chemotherapeutic formulation comprising a chemotherapeutic compound.

### Claim 30

A method of relieving side effects of a chemotherapeutic compound in a mammal comprising administering a composition comprising:
i) a pharmaceutically acceptable carrier;
ii) an herbal preparation comprising Scutellaria, Glycyrrhiza, Ziziphus and Paeonia; and
iii) a chemotherapeutic formulation comprising the chemotherapeutic compound.

### Claim 31 (depends on 30)

The method of claim 30, wherein the mammal is a human.

### Claim 32

A method of enhancing therapeutic effectiveness of a chemotherapeutic formulation in a mammal comprising administering a composition comprising:
i) a pharmaceutically acceptable carrier;
ii) an herbal preparation comprising Scutellaria, Glycyrrhiza, Ziziphus and Paeonia; and
iii) the chemotherapeutic formulation comprising a chemotherapeutic compound.

### Claim 33 (depends on 32)

The method of claim 32, wherein the mammal is a human.

### Claim 34

A method of enhancing antitumor activity of a chemotherapeutic compound in a mammal comprising administering a composition comprising:
i) a pharmaceutically acceptable carrier;
ii) an herbal preparation comprising Scutellaria, Glycyrrhiza, Ziziphus and Paeonia; and
iii) a chemotherapeutic formulation comprising the chemotherapeutic compound.

### Claim 35 (depends on 34)

The method of claim 34, wherein the mammal is a human.

### Claim 36

A method of using a chemotherapeutic agent, comprising administering a composition comprising:
i) a pharmaceutically acceptable carrier;
ii) an herbal preparation comprising Scutellaria, Glycyrrhiza, Ziziphus and Paeonia; and
iii) a chemotherapeutic formulation comprising a chemotherapeutic compound.

### Claim 37

A method of treatment comprising a chemotherapeutic regimen comprising a chemotherapeutic compound and a composition comprising:
i) a pharmaceutically acceptable carrier; and.
ii) an herbal preparation comprising Scutellaria, Glycyrrhiza, Ziziphus and Paeonia.

### Claim 38

A therapeutic regimen comprising a chemotherapeutic compound and a composition comprising:
i) a pharmaceutically acceptable carrier; and
ii) an herbal preparation comprising Scutellaria, Glycyrrhiza, Ziziphus and Paeonia.

### Claim 39 (depends on 1)

The composition of claim 1, wherein the composition comprises three chemotherapeutic compounds.

### Claim 40 (depends on 39)

The composition of claim 39, wherein the chemotherapeutic compounds are CPT-11, FU, and LV.

### Claim 41 (depends on 25)

The composition of claim 25, wherein the chemotherapeutic formulation comprises three chemotherapeutic compounds.

### Claim 42 (depends on 41)

The composition of claim 41, wherein the chemotherapeutic compounds are CPT-11, FU, and LV.

### Claim 43 (depends on 11, 13)

The method of any one of claims 11, 13, or 23, wherein the method comprises administering three chemotherapeutic compounds.

### Claim 44 (depends on 43)

The method of claim 43, wherein the three chemotherapeutic compounds are CPT-11, FU, and LV.

### Claim 45 (depends on 29, 30, 32, 34, 36)

The method of any one of claims 29, 30, 32, 34, 36, or 37, wherein the method comprises a chemotherapeutic formulation including three chemotherapeutic compounds.

### Claim 46 (depends on 45)

The method of claim 45, wherein the three chemotherapeutic compounds are CPT-11, FU, and LV.

### Claim 47

A composition comprising:
i) a pharmaceutically acceptable carrier;
ii) material or chemical from a plant species of each of the following genera of herbs: Scutellaria, Glycyrrhiza, Ziziphus and Paeonia; and
iii) one or more antiviral agents.

### Claim 48 (depends on 47)

The composition of claim 47 wherein the plant species are Scutellaria baicalensis, Glycyrrhiza uralensis, Ziziphus jujuba, and Paeonia lactiflora.

### Claim 49 (depends on 47)

The composition of claim 47 wherein the one or more antiviral agents are antiretroviral agents.

### Claim 50 (depends on 47)

The composition of claim 47 wherein the antiviral agents are selected from the group consisting of AZT, DDI, 3TC, and D4T.

### Claim 51 (depends on 47)

The composition of claim 47 wherein the composition comprises three antiviral agents.

### Claim 52 (depends on 51)

The composition of claim 51, wherein the three antiviral agents are selected from the group comprising 1) d4T, 3TC, and protease inhibitor; 2) AZT, 3TC, and protease inhibitor; and 3) AZT, DDI, and protease inhibitor.

### Claim 53 (depends on 52)

The composition of claim 52 wherein the protease inhibitor is selected from the group consisting of nelfinavir, indinavir, saquinavir and ritonavir.

### Claim 54

A method of treating a patient in need thereof comprising administering a therapeutically effective amount of a composition comprising:
i) a pharmaceutically acceptable carrier;
ii) material or chemical from a plant species of each of the following genera of herbs: Scutellaria, Glycyrrhiza, Ziziphus and Paeonia; and
iii) one or more antiviral agents.

### Claim 55

A method of enhancing the therapeutic effectiveness of an antiviral therapy comprising administering a therapeutically effective amount of a composition comprising:
i) a pharmaceutically acceptable carrier;
ii) material or chemical from a plant species of each of the following genera of herbs: Scutellaria, Glycyrrhiza, Ziziphus and Paeonia; and
iii) one or more antiviral agents.

### Claim 56

A method of enhancing the antiviral activity of an antiviral therapy of comprising administering a therapeutically effective amount of a composition comprising:
i) a pharmaceutically acceptable carrier;
ii) material or chemical from a plant species of each of the following genera of herbs: Scutellaria, Glycyrrhiza, Ziziphus and Paeonia; and
iii) one or more antiviral agents.
